PATLY.AIApplication
17620541 · AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME
Filed 2021-12-17 · Pending The official file ↗ · Art unit 1693 · Examiner Layla D Berry Typical · CPC A61P 35/02 · CELGENE CORPORATION · FOLEY & LARDNER LLP
Office actions
5
first was Restriction requirement
RCEs
2
no appeal
To first action
33.8 mo
to disposition n/a
Statutes raised
103 112 DP
5 actions read